Akhil leads the clinical development department at Aurigene. After completing his MBBS from AIIMS, New Delhi, in 1995, he completed his residency training in Internal Medicine and Clinical Fellowship in Hematology and Oncology from the Rutgers Cancer Institute of New Jersey. He has been in the industry for more than 20 years, with both big pharma as well as small biotech companies. He has been part of two successful New Drug Applications to the US FDA and has also led about 20 IND applications to US FDA and about 10 IND applications to DCGI, India. He established the clinical development department at Aurigene and works with cross-functional teams like pharmacology, pharmacokinetics and toxicology. In addition, while at Aurigene, he has also established the CGT (Cell and Gene Therapy) vertical, including a GMP facility for clinical trials.  Akhil has been with Aurigene since 2017.